Dr. Irina V Koreen, MD, PHD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1 Hatfield Ln, Goshen, NY 10924 Phone: 845-294-5128 Fax: 845-294-1479 |
Dr. Mandes R Kates, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1 Hatfield Ln, Suite 3, Goshen, NY 10924 Phone: 845-294-5128 Fax: 845-294-1479 |
Dr. Leslie J Green, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1 Hatfield Ln, Ste 3 Eye Physicians Of Orange County Pc, Goshen, NY 10924 Phone: 845-294-5128 Fax: 845-294-1479 |
Dr. Ramon B. Ruffy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7 Hatfield Ln, Goshen, NY 10924 Phone: 845-703-6999 Fax: 845-703-6297 |
Vincent Paul Moscato, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7 Hatfield Ln, Goshen, NY 10924 Phone: 845-703-6999 Fax: 845-703-6297 |
Dr. Mark J Stamm, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1 Hatfield Ln, Ste 3 Eye Physicians Of Orange County Pc, Goshen, NY 10924 Phone: 845-294-5128 Fax: 845-294-1479 |
Dr. Yochanan Burnstein, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 1 Hatfield Lane, Eye Physicians Of Orange County, Pc, Goshen, NY 10924 Phone: 845-294-5128 Fax: 845-294-1479 |
News Archive
BAZI International, Inc. announced today that the Company has signed an agreement with a national fitness center for distribution in nearly 100 fitness centers, most of which offer access for members 24 hours a day.
Inflammation is the response of our immune system to infection and harmful environmental effects. On one hand, it is beneficial as it defends our body against microbes. On the other hand, excessive inflammation leads to serious diseases.
A new study investigates how age influences SARS-CoV-2 replication, innate and adaptive immune responses.
MacroGenics, Inc., a leader in next-generation antibody platforms and therapeutics, announced today that it has entered into a global research collaboration and license agreement with Pfizer Inc. to discover, develop and commercialize Dual-Affinity Re-Targeting (DART) products directed at two undisclosed cancer targets.
› Verified 2 days ago